全文获取类型
收费全文 | 15184篇 |
免费 | 650篇 |
国内免费 | 70篇 |
专业分类
耳鼻咽喉 | 89篇 |
儿科学 | 199篇 |
妇产科学 | 117篇 |
基础医学 | 1983篇 |
口腔科学 | 322篇 |
临床医学 | 1126篇 |
内科学 | 3982篇 |
皮肤病学 | 270篇 |
神经病学 | 1239篇 |
特种医学 | 844篇 |
外科学 | 2638篇 |
综合类 | 79篇 |
一般理论 | 1篇 |
预防医学 | 338篇 |
眼科学 | 305篇 |
药学 | 929篇 |
中国医学 | 24篇 |
肿瘤学 | 1419篇 |
出版年
2022年 | 134篇 |
2021年 | 229篇 |
2020年 | 134篇 |
2019年 | 159篇 |
2018年 | 235篇 |
2017年 | 186篇 |
2016年 | 191篇 |
2015年 | 241篇 |
2014年 | 299篇 |
2013年 | 365篇 |
2012年 | 504篇 |
2011年 | 645篇 |
2010年 | 335篇 |
2009年 | 298篇 |
2008年 | 533篇 |
2007年 | 603篇 |
2006年 | 560篇 |
2005年 | 581篇 |
2004年 | 579篇 |
2003年 | 638篇 |
2002年 | 615篇 |
2001年 | 605篇 |
2000年 | 622篇 |
1999年 | 572篇 |
1998年 | 206篇 |
1997年 | 175篇 |
1996年 | 138篇 |
1995年 | 136篇 |
1994年 | 142篇 |
1993年 | 100篇 |
1992年 | 482篇 |
1991年 | 364篇 |
1990年 | 405篇 |
1989年 | 400篇 |
1988年 | 378篇 |
1987年 | 343篇 |
1986年 | 327篇 |
1985年 | 359篇 |
1984年 | 210篇 |
1983年 | 198篇 |
1982年 | 87篇 |
1979年 | 169篇 |
1978年 | 100篇 |
1977年 | 108篇 |
1975年 | 91篇 |
1973年 | 99篇 |
1971年 | 90篇 |
1969年 | 97篇 |
1968年 | 105篇 |
1967年 | 85篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Konishi T Noie T Abe T Agawa S Furushima K Ito K Mafune K Makuuchi M Teruya M Nouchi T 《Gan to kagaku ryoho. Cancer & chemotherapy》1999,26(4):431-439
The first clinical application of biochemical modulation (BCM) of 5-fluorouracil (5-FU) was the sequential MTX/5-FU regimen proposed in 1977 by Bertino for the treatment of colorectal cancer. In Japan, sequential MTX/5-FU therapy was mainly used as a new method of treating gastric cancer, and attracted a great deal of attention because it proved effective in many cases of advanced gastric cancer that had been unresponsive to the previous chemotherapy, particularly scirrhous gastric cancer with poor prognosis. Its therapeutic efficacy varied according to histologic type, it was effective in cases of peritoneal dissemination and disseminated intravascular coagulopathy (DIC), it was associated with fewer adverse effects, and it was a multidrug chemotherapy based on a clear rationale. With sequential MTX/5-FU therapy as a starting point, fundamental studies of BCM and its clinical applications have expanded rapidly in Japan. This paper provides an outline of sequential MTX/5-FU therapy from the aspects of its mechanism of action, indications, therapeutic efficacy, relevance to adjuvant therapy, counter-measures to adverse effects, and emergence of resistance to the drugs involved. The high therapeutic efficacy of this therapy in certain histologic types is also discussed, and its combined use with other forms of BCM, as in triple BCM (LV/5-FU + CDDP/5-FU + MTX/5-FU), is introduced. 相似文献
992.
K Kohshi Y Kinoshita H Imada N Kunugita H Abe H Terashima N Tokui S Uemura 《British journal of cancer》1999,80(1-2):236-241
The purpose of this non-randomized trial was to evaluate the efficacy of radiotherapy combined with hyperbaric oxygen (HBO) in patients with malignant glioma. Between 1987 and 1997, 29 patients in whom computerized tomography (CT) or magnetic resonance imaging (MRI) scans showed post-operative residual tumours were locally irradiated with nitrosourea-based chemotherapy. Treatments were consecutively combined with HBO at two institutions since 1991 and 1993. Fifteen patients were irradiated daily after HBO, and the periods of time from decompression to irradiation were within 15 and 30 min in 11 and four patients respectively. Fourteen other patients were treated without HBO. Tumour responses were assessed by CT or MRI scans and survival times were compared between the treated groups. In the HBO group, 11 of 15 patients (73%) showed > or = 50% tumour regression. All responders were irradiated within 15 min after decompression. In the non-HBO group, four of 14 patients (29%) showed tumour regression. The median survivals in patients with and without HBO were 24 and 12 months, respectively, and were significantly different (P < 0.05). No serious side-effects were observed in the HBO patients. In conclusion, irradiation after HBO seems to be a useful form of treatment for malignant gliomas, but irradiation should be administered immediately after decompression. 相似文献
993.
The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma. 总被引:6,自引:0,他引:6
N Iizuka K Hirose T Noma S Hazama A Tangoku H Hayashi T Abe K Yamamoto M Oka 《British journal of cancer》1999,81(3):469-475
Recently, nm23-H1, an anti-metastasis gene, has been reported to correlate with sensitivity to chemotherapeutic agents including cisplatin in human breast and ovarian carcinoma cells. The aim of this study was to evaluate a role for nm23-H1 in responsiveness to cisplatin-based chemotherapy in patients with oesophageal squamous cell carcinoma (OSCC). The expression of nm23-H1 protein was examined immunohistochemically in 32 eligible patients with OSCC who underwent adjuvant chemotherapy with cisplatin, etoposide, and 5-fluorouracil after tumour resection. Fifteen (46.9%) of 32 patients were positive for nm23-H1 staining and 17 (53.1%) were negative. Both disease-free survival and overall survival rates of nm23-H1-negative patients were significantly shorter than in nm23-H1-positive patients (P < 0.01 for both). There was no significant difference in clinicopathologic characteristics between nm23-H1-positive and nm23-H1-negative groups. Multivariate analysis also showed that nm23-H1 expression was the most significant factor for overall survival of OSCC patients included in this study (P = 0.0007). To further study the role of nm23-H1, a human OSCC cell line (YES-2) was transfected with a plasmid containing a fragment of the nm23-H1 cDNA in an antisense orientation. Reduced expression of nm23-H1 protein in the antisense-transfected (AS) clones was found by Western blot analysis as compared to wild-type YES-2 and YES-2/Neo (clone transfected with the neomycin resistance gene alone). MTT (3-(4,5-dimethyl-2-thiazol)-2,5-diphenyl-2H tetrazolium bromide) assay showed that reduced expression of the nm23-H1 protein in AS clones was consistent with the degree of increased resistance to cisplatin but not etoposide or 5-fluorouracil. These data support the conclusion that reduced expression of nm23-H1 may be associated with resistance to cisplatin, suggesting the value of nm23-H1 expression as a prognostic marker for OSCC patients who are to undergo cisplatin-based chemotherapy. 相似文献
994.
995.
Efficacy of the mobilization of peripheral blood stem cells by granulocyte colony-stimulating factor in pediatric donors. 总被引:1,自引:0,他引:1
Y Kawano Y Takaue T Watanabe T Abe Y Okamoto A Iwai T Iwai A Watanabe E Ito A Makimoto R Nakagawa H Watanabe J Sato K Suenaga H Suzuya T Ohnishi S Kanamaru M Kaneko Y Kuroda 《Cancer research》1999,59(14):3321-3324
The advantages/disadvantages of the use of peripheral blood stem cells (PBSCs) for allogeneic transplantation still need to be clarified, particularly in children. We compared the kinetics, efficacy, and safety of PBSC mobilization by granulocyte colony-stimulating factor (G-CSF) and collection by apheresis between healthy pediatric and adult donors. A total of 19 pediatric (median age, 6 years) and 25 adult healthy donors (median age, 37 years) were given 10 micro/kg/day of G-CSF for 5 consecutive days for PBSC mobilization, which were harvested by apheresis on days 5 and/or 6. All of the donors tolerated the whole procedures. Serum trough levels of G-CSF determined by ELISA were significantly lower in the 16 pediatric donors evaluated than in adults (n = 16) on days 3 and 4 (P < 0.05). Although the WBC counts on days 4 and 5 were significantly higher in adults than in children (P = 0.006 and 0.004, respectively), the numbers of circulating CD34+ cells/unit of blood were identical. The number of blood CD34+ cells collected per unit of blood processed was identical in both donor populations. We propose that PBSCs could be effectively mobilized and collected in small children so that they could be donors for adult patients. 相似文献
996.
The pharmacological activity of a novel cyclic peptide (SEK-1005: C(45)H(70)N(8)0(13)) isolated from Streptomyces nobilis was studied in rats during the development of inflammation. SEK-1005 (0.1-0.5 mg/kg, i.p.) suppressed the passive Arthus reaction and the carrageenin-induced oedema. A steroidal anti-inflammatory drug, prednisolone (10 mg/kg, i.p.), also was effective on both inflammations. However, indomethacin (5 mg/kg, i.p.), a cyclooxygenase inhibitor, was less effective on the passive Arthus reaction. Also interesting was that the SEK-1005 effect showed its maximum level after a 24-h lag period and that its effect, as well as the prednisolone effect, was reduced by the treatment with a protein synthesis inhibitor, cycloheximide. SEK-1005 and prednisolone also showed marked protection against the adjuvant-induced arthritis, but failed to prevent the tuberculin response. These findings indicate that SEK-1005 is a new type of non-steroidal anti-inflammatory agent with an action similar to that of prednisolone. 相似文献
997.
Wound healing acceleration of a novel transforming growth factor-beta inducer, SEK-1005 总被引:1,自引:0,他引:1
The studies were carried out to elucidate the effect of a novel cyclic peptide, SEK-1005 (C(45)H(70)N(8)O(13)), on wound healing. SEK-1005 (4-10 microg/wound) applied topically significantly accelerated the healing of a full-thickness wound on the dorsal skin of a rat. In a healing-impaired mouse, the peptide (2-10 microg/wound) had more potent activity, exerting an effect comparable to that of basic fibroblast growth factor (FGF). However, SEK-1005 (0.1-100 ng/ml) scarcely promoted the proliferation of cultured fibroblasts (NIH3T3 cells) while basic FGF (0.2-5 ng/ml) showed marked mitogenic activity. SEK-1005 (2-10 microg/wound) significantly increased the topical production of transforming growth factor (TGF)-beta1, a cytokine that is known to accelerate wound healing. This activity was closely correlated with the wound-repairing effect. From the above, SEK-1005 can be considered as a new type of wound healing agent with potent TGF-beta1-inducing activity. 相似文献
998.
This study was planned to determine the effects and possible mechanism of action of phenytoin on development of the reproductive tract and first ovulation in immature rats. Rats were injected s.c. with 5 IU of equine chorionic gonadotrophin (equine CG) on day 26 to induce ovarian and uterine development. Treatment with phenytoin (140 mg/kg) at 1200 h on day 28, which induces serum levels approximately twice those reached with the clinical dose as anticorvulsant drug for humans, was effective for inhibiting the first ovulation and normal secretion of serum follicle - stimulating hormone and luteinizing hormone (LH) on day 29 as well as the preovulatory gonadotrophin surge on day 28. The block of ovulation was overcome by administration of human chorionic gonadotrophin or LH-releasing hormone on day 28. Simultaneous treatment with equine CG and phenytoin at 0800 h on day 26 did not affect either ovarian weight or ovarian hormones secretion, whereas phenytoin clearly inhibited the normal increase in uterine weight on day 27. Furthermore, phenytoin suppressed uterine growth after 17beta-oestradiol injection. These results indicate that phenytoin inhibits the first ovulation by inhibiting the gonadotrophin surge and further, that the drug impairs the stimulatory effects of oestrogen on uterine proliferation in the gonadotropin-induced ovulation model. 相似文献
999.
Tomoyasu Abe Taku Asano Taketoshi Manabe Hiroo Matsuura Tomohisa Furuta Kohji Taguchi 《Brain tumor pathology》1999,16(1):49-53
We present the case of an 8-year-old girl with a ganglioneuroma in the left cerebellopontine angle region. The tumor originated
from the sensory root of the trigeminal nerve. Histopathologically, it was composed of neoplastic ganglion cells and Schwann
cells, leading us to the diagnosis of ganglioneuroma. Intracranial ganglioneuroma is very rare. To our knowledge, this is
the first report of a trigeminal ganglioneuroma. The nature and origin of this tumor are discussed and the literature reviewed. 相似文献
1000.